2.75
price up icon1.48%   0.04
after-market Handel nachbörslich: 2.71 -0.04 -1.45%
loading
Schlusskurs vom Vortag:
$2.71
Offen:
$2.96
24-Stunden-Volumen:
11.62M
Relative Volume:
5.72
Marktkapitalisierung:
$474.18M
Einnahmen:
$314.00K
Nettoeinkommen (Verlust:
$-40.23M
KGV:
-9.8214
EPS:
-0.28
Netto-Cashflow:
$-84.71M
1W Leistung:
+25.00%
1M Leistung:
+10.44%
6M Leistung:
+71.87%
1J Leistung:
+111.54%
1-Tages-Spanne:
Value
$2.66
$2.96
1-Wochen-Bereich:
Value
$2.15
$2.96
52-Wochen-Spanne:
Value
$1.03
$2.96

Atai Life Sciences N V Stock (ATAI) Company Profile

Name
Firmenname
Atai Life Sciences N V
Name
Telefon
49 89 2153 9035
Name
Adresse
WALLSTRASSE 16, BERLIN
Name
Mitarbeiter
54
Name
Twitter
Name
Nächster Verdiensttermin
2024-12-11
Name
Neueste SEC-Einreichungen
Name
ATAI's Discussions on Twitter

Vergleichen Sie ATAI mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ATAI
Atai Life Sciences N V
2.75 474.18M 314.00K -40.23M -84.71M -0.28
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Atai Life Sciences N V Stock (ATAI) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-11-18 Bestätigt H.C. Wainwright Buy
2024-04-03 Hochstufung Maxim Group Hold → Buy
2022-11-01 Eingeleitet Loop Capital Buy
2021-11-30 Eingeleitet Maxim Group Buy
2021-11-11 Eingeleitet ROTH Capital Buy
2021-10-18 Eingeleitet H.C. Wainwright Buy
2021-09-01 Eingeleitet Jefferies Buy
2021-07-13 Eingeleitet Berenberg Buy
2021-07-13 Eingeleitet Canaccord Genuity Buy
2021-07-13 Eingeleitet Cantor Fitzgerald Buy
2021-07-13 Eingeleitet Citigroup Buy
2021-07-13 Eingeleitet Cowen Outperform
2021-07-13 Eingeleitet Credit Suisse Outperform
2021-07-13 Eingeleitet RBC Capital Mkts Sector Perform
2021-07-08 Eingeleitet Aegis Capital Buy
Alle ansehen

Atai Life Sciences N V Aktie (ATAI) Neueste Nachrichten

pulisher
Jun 18, 2025

ATAI Sees Potential Boost from U.S. Policy Shift on Psychedelics - GuruFocus

Jun 18, 2025
pulisher
Jun 15, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, ATAI, ICAD on Behalf of Shareholders - GlobeNewswire

Jun 15, 2025
pulisher
Jun 15, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, ATAI, ICAD on Behalf of Shareholders - GlobeNewswire Inc.

Jun 15, 2025
pulisher
Jun 13, 2025

ATAI’s Stock Dilemma: ATAI Life Sciences N.V’s Market Performance and Outlook - investchronicle.com

Jun 13, 2025
pulisher
Jun 13, 2025

SELLAS Life Sciences Group Inc (SLS) Stock: A Year of Highs and Lows - investchronicle.com

Jun 13, 2025
pulisher
Jun 12, 2025

Atai Life Sciences (ATAI) Garnered a Buy Rating and $12 Target | ATAI Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 09, 2025

Are You Looking for a Top Momentum Pick? Why atai Life Sciences N.V. (ATAI) is a Great Choice - Yahoo Finance

Jun 09, 2025
pulisher
Jun 09, 2025

Is atai Life Sciences (ATAI) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Jun 09, 2025
pulisher
Jun 07, 2025

Lucid Capital Markets initiates coverage on atai Life Sciences stock By Investing.com - Investing.com Nigeria

Jun 07, 2025
pulisher
Jun 06, 2025

ATAI Gains Buy Rating and Price Target from Lucid Capital | ATAI Stock News - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Lucid Capital Markets initiates coverage on atai Life Sciences stock - Investing.com

Jun 06, 2025
pulisher
Jun 05, 2025

ATAI and Beckley Psytech Set to Merge in Strategic All-Share Dea - GuruFocus

Jun 05, 2025
pulisher
Jun 04, 2025

Regeneron makes obesity push; Atai, Alto ink brain drug deals - Yahoo Finance

Jun 04, 2025
pulisher
Jun 03, 2025

Atai Life Sciences Merges With Beckley Psytech In Major Shakeup - Finimize

Jun 03, 2025
pulisher
Jun 03, 2025

ATAI Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Atai Life Sciences N.V. is Fair to Shareholders - Business Wire

Jun 03, 2025
pulisher
Jun 03, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BPMC, STRM, ATAI, STR on Behalf of Shareholders - Morningstar

Jun 03, 2025
pulisher
Jun 03, 2025

H.C. Wainwright maintains buy rating on atai Life Sciences stock By Investing.com - Investing.com India

Jun 03, 2025
pulisher
Jun 03, 2025

H.C. Wainwright maintains buy rating on atai Life Sciences stock - Investing.com

Jun 03, 2025
pulisher
Jun 03, 2025

Atai in $370M merger deal with psychedelic drug specialist Beckley - BioWorld MedTech

Jun 03, 2025
pulisher
Jun 02, 2025

atai Life Sciences (ATAI) Merges with Beckley Psytech for Psyche - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

atai Life Sciences and Beckley Psytech merging - Seeking Alpha

Jun 02, 2025
pulisher
Jun 02, 2025

Atai Life Sciences, Beckley Psytech to Merge in All-Stock Transaction - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Transcript : Atai Life Sciences N.V., Beckley Psytech LimitedM&A Call - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Thiel-Backed Psychedelic Drugmaker Atai to Combine With Beckley - Bloomberg

Jun 02, 2025
pulisher
Jun 02, 2025

ATAI and Beckley Psytech Plan Merger in Strategic All-Share Deal | ATAI Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic Mental Health Therapies - Yahoo Finance

Jun 02, 2025
pulisher
Jun 02, 2025

ATAI Life Sciences stock soars on Beckley Psytech merger deal By Investing.com - Investing.com UK

Jun 02, 2025
pulisher
May 30, 2025

Beckley Psytech & atai Life Sciences to combine expertise in pivotal merger - Mugglehead Magazine

May 30, 2025
pulisher
May 29, 2025

atai Life Sciences to Participate in Upcoming Investor Conferences - Yahoo

May 29, 2025
pulisher
May 27, 2025

2 ‘Strong Buy’ Psychedelic Stocks To Scoop Up ASAP - Barchart.com

May 27, 2025
pulisher
May 24, 2025

Ex-Gov't Foe Joins Trump, RFK Jr.'s HHS To Lead Psychedelics Policy: What It Means For Investors - Benzinga

May 24, 2025
pulisher
May 23, 2025

atai Life Sciences N.V. (ATAI) Is Up 18.71% in One Week: What You Should Know - Nasdaq

May 23, 2025
pulisher
May 22, 2025

atai Life Sciences N.V. (ATAI) Just Flashed Golden Cross Signal: Do You Buy? - sharewise

May 22, 2025
pulisher
May 22, 2025

Is atai Life Sciences (ATAI) Outperforming Other Medical Stocks This Year? - Yahoo Finance

May 22, 2025
pulisher
May 21, 2025

atai Life Sciences holds annual general meeting - Investing.com Australia

May 21, 2025
pulisher
May 21, 2025

atai Life Sciences holds annual general meeting By Investing.com - Investing.com India

May 21, 2025
pulisher
May 21, 2025

ATAI Life Sciences Approves Key Governance Changes - TipRanks

May 21, 2025
pulisher
May 21, 2025

Phase 2a data for BPL-003 ‘encouraging’ for Atai Life Sciences, says Jefferies - Yahoo Finance

May 21, 2025
pulisher
May 21, 2025

ATAI Life Sciences Sees Significant Rise in Borrow Rate | ATAI S - GuruFocus

May 21, 2025

Finanzdaten der Atai Life Sciences N V-Aktie (ATAI)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Atai Life Sciences N V-Aktie (ATAI) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Kirpekar Sahil
Chief Business Officer
Mar 21 '25
Sale
1.35
48,563
65,560
115,636
Craig Kevin James
Chief Medical Officer
Mar 21 '25
Sale
1.35
11,563
15,610
8,437
Rao Srinivas
See Remarks
Mar 21 '25
Sale
1.35
75,418
101,814
212,942
Johnson Anne Nagengast
Chief Financial Officer
Mar 21 '25
Sale
1.35
33,545
45,286
140,045
Short Glenn Frank
Chief Scientific Officer
Mar 21 '25
Sale
1.35
13,161
17,767
42,333
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):